Transforming Precision Medicine with rapid Predictive AI Biomarkers
At BioAI, we use cutting-edge AI to develop advanced tests and biomarker panels from tumor tissue. Our goal is to provide clinicians with early insights for faster, more accurate treatment decisions and improved patient outcomes.
From Weeks to Hours
High-Speed Biomarker Screening from Tumor Tissue
Biopharma Solutions
Custom AI models for screening genetic mutations and biomarkers across different cancer types
Clinical Diagnostics
Derive early insights with PredictLung to inform patient therapy decision-making in minutes
Data Sourcing Services
Gain access to difficult-to-find datasets and biospecimen by leveraging BioAI’s concierge services
Experience the Future of Precision Medicine
Partner with BioAI, accelerate your path in clinical R&D, and leverage the novel capabilities of our AI services:
- Cutting-edge multimodal causal AI
- A unique expertise and know-how in In-silico phenotype projection
- Multimodal data analysis including spatial transcriptomics
- Extensive experience in computational pathology on H&E-, IHC- and FISH-stained tissue slides
- Sourcing required data through BioAI’s network of data-access-partners
- Biomedical guidance through our experienced board-certified pathologists and translational scientists
- Optimization and validation of AI models
- Productization and deployment of digital tests
- Partnering with clinical laboratories or IVD manufacturers where needed
Why Choose BioAI for Your R&D Journey
AI Pioneers
Access BioAI's PredictX-Platform featuring world-leading multimodal technology, including Causal AI and in-silico phenotype projection. Understand disease biology, create sustainable AI models, identify causal dependencies and drug targets, and speed up drug approval processes.
Cross-Disciplinary Expertise
We’re not just another tech startup. Our team is led by industry experts, each with 25+ years of experience. With world renowned AI expertise and profound knowledge of drug development processes and biomarker programs, BioAI has established successful partnerships throughout Biopharma.
Innovative Digital Biomarker Solutions
Build novel precision diagnostic assays. Expand access to eligible patients for clinical studies using H&E-based screening that is rapid, globally accessible, and cost-efficient. Match patients to the most effective therapies. High fidelity, high definition.
Data Security & Peace of Mind
We understand the importance of data security in this industry. We handle patient data and research with the utmost care and confidentiality, ensuring compliance with regulatory standards. When working with our partners, we promise peace of mind.